Oakworth Capital, Inc. Gilead Sciences, Inc. Transaction History

Oakworth Capital, Inc.

$1.44 Billion
Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oakworth Capital, Inc. holds 4,306 shares of GILD stock, worth $388,358. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,306

Previous 4,306 -0.0%

Holding current value

$388,358

Previous $295,000 22.03%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $8,633 - $9,861	-145 Reduced 3.26%	4,306 $266,000
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $7,965 - $8,971	-138 Reduced 3.01%	4,451 $275,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $54,434 - $61,783	-839 Reduced 15.46%	4,589 $333,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $76,164 - $83,220	-1,200 Reduced 18.11%	5,428 $374,000
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $91,380 - $104,264	-1,523 Reduced 18.68%	6,628 $428,000
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $98,180 - $123,444	-1,581 Reduced 16.25%	8,151 $515,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $10,851 - $12,600	150 Added 1.57%	9,732 $749,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $100,709 - $128,993	1,608 Added 20.17%	9,582 $716,000
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $6,531 - $7,184	-106 Reduced 1.31%	7,974 $525,000
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $8,785 - $9,851	142 Added 1.79%	8,080 $546,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $160,076 - $179,328	-2,560 Reduced 24.39%	7,938 $516,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $129,373 - $168,823	2,137 Added 25.56%	10,498 $657,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $59,875 - $66,292	-840 Reduced 9.13%	8,361 $645,000
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $122,688 - $143,110	1,891 Added 25.87%	9,201 $652,000
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $22,625 - $26,559	-318 Reduced 4.17%	7,310 $547,000
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $550,055 - $651,965	7,628	7,628 $638,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Gilead Sciences, Inc. Transaction History